26 December 2024
Sidley Advises on Mankind Pharma Limited’s US$350 Million QIP
Advising firms
Deal team
9 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Manoj Bhargava Lead | Sidley | Partner | Not stated | Not stated |
| Joel Lam | Sidley | Other | Not stated | Not stated |
| Jeffrey R. Dohoda | Sidley | Associate | Not stated | Not stated |
| Kristine Zhang | Sidley | Other | Not stated | Not stated |
| Carla G. Teodoro | Sidley | Partner | Not stated | Not stated |
| Nicholas R. Brown | Sidley | Partner | Not stated | Not stated |
| Prabhat K. Mehta | Sidley | Partner | Not stated | Not stated |
| Alvin Wang | Sidley | Other | Not stated | Not stated |
| Michael H. Sliskovich | Sidley | Associate | Not stated | Not stated |
6 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 350m (US$350 million)
- What the figure measures
- Issue size
- Client
- Mankind Pharma LimitedIssuer
- Counterparties
- Kotak Mahindra Capital Company Limited (Underwriters)
IIFL Capital Services Limited (Underwriters)